FDA Approval of Kalydeco

0 Flares Filament.io 0 Flares ×

FDA Approval of Kalydeco

Kalydeco (formerly known as VX-770) was developed by Vertex Pharmaceuticals Inc. with significant support from the CF Foundation in a collaboration that began more than a decade ago. The FDA approved Kalydeco on Jan. 31, 2012, for people with the G551D mutation of CF ages 6 and older.

For more information go to Cystic Fibrosis Foundation’s website.

0 Flares Twitter 0 Facebook 0 Filament.io 0 Flares ×

Leave a Reply

Your email address will not be published. Required fields are marked *

CommentLuv badge